Pfizer (PFE) Tops Q3 EPS by 29c, Raises FY Guidance

Pfizer (NYSE: PFE) reported Q3 EPS of $1.37, $0.29 better than the analyst estimate of $1.08. Revenue for the quarter came in at $24.1 billion versus the consensus estimate of $22.68 billion.

GUIDANCE:

Pfizer sees 2021 EPS of $4.13-$4.18 (previously $3.95 to $4.05). Pfizer sees 2021 revenue of $81-82 billion (previously $78.0 to $80.0 billion).

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14